Arcturus Therapeutics Holdings Profit Margin

Arcturus Therapeutics Holdings (ARCT) currently reports a profit margin of -350.86% as of June 2026. That compares with -41.08% in the prior-year period — down 754.1% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Arcturus Therapeutics Holdings's profit margin history and peer comparisons.

Arcturus Therapeutics Holdings's profit margin decreased from -41.08% to -350.86% — a 754.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arcturus Therapeutics Holdings's profit margin of -350.86% is lower than the Healthcare sector average of 9.48%. That is roughly 3800.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Arcturus Therapeutics Holdings's current -350.86% should be judged against Healthcare norms (sector average: 9.48%) and against ARCT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -350.86%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Arcturus Therapeutics Holdings, and consider following ARCT for alerts when major investors trade the stock.